cyc 682 has been researched along with tocophersolan in 1 studies
| Studies (cyc 682) | Trials (cyc 682) | Recent Studies (post-2010) (cyc 682) | Studies (tocophersolan) | Trials (tocophersolan) | Recent Studies (post-2010) (tocophersolan) |
|---|---|---|---|---|---|
| 30 | 5 | 18 | 578 | 10 | 469 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuno, T; Kurimoto, I; Obata, T; Ogawa, N; Sasaki, T; Suzuki, Y; Tanaka, M; Yamamoto, H | 1 |
1 other study(ies) available for cyc 682 and tocophersolan
| Article | Year |
|---|---|
Improvement of the antitumor activity of poorly soluble sapacitabine (CS-682) by using Soluplus® as a surfactant.
Topics: Animals; Antineoplastic Agents; Arabinonucleosides; Cell Line, Tumor; Cytosine; Dose-Response Relationship, Drug; Mice; Polyethylene Glycols; Polysorbates; Polyvinyls; Solubility; Surface-Active Agents; Survival Analysis; Vitamin E | 2014 |